As of August 28, 2026, Impact BioMedical Inc. (IBO) has a DilutionWatch DilutionScore of 67/100, rated HIGH dilution risk. Impact BioMedical Inc. has a market capitalization of $56.07M, 107.82M shares outstanding, 22 institutional holders tracked.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Dilution Forecast
⛈️
Warning
High probability of dilution event
model est. 53%
🔄 Reverse Split
model est. 70%
• 50-day avg $0.62 below $1 exchange minimum
• Only 0 months cash — financial pressure
💰 Capital Raise
model 55%
• Critical: only 0.1 months cash remaining
📉 Score Deterioration
model 10%
• Score in HIGH risk zone (67/100)
Market Data
Market Cap$56.07M
Shares Outstanding107.82M
Float11.44M
Cash$20.0K
Debt$11.90M
Short InterestN/A
Institutional Holdings
QoQ: ↑ 209.1% shares (2026Q1 vs prior)
22 institutional holders · 4.45M shares
#1
VANGUARD CAPITAL MANAGEMENT LLC
1.42M shares
#2
GEODE CAPITAL MANAGEMENT, LLC
1.19M shares
#3
STATE STREET CORP
607.9K shares
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Short Interest554.9K
Days to Cover27.1
% of Float4.8%
FINRA data as of Jul 31, 2026
Recent SEC Activity
No recent SEC insights
Recent News
No recent news
Track IBO Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking IBO — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
More Research for IBO
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.